Mads Krogsgaard Thomsen
About Mads Krogsgaard Thomsen
Mads Krogsgaard Thomsen is a distinguished professor and CEO with a strong background in veterinary medicine and pharmacology, known for his significant contributions to the development of over 20 pharmaceutical products.
Mads Krogsgaard Thomsen's Current Roles
Mads Krogsgaard Thomsen holds prominent positions as a Professor and CEO. He has been an adjunct professor of pharmacology at the Faculty of Health Sciences at the University of Copenhagen since 2000. Additionally, he serves on the board of BB Biotech AG, showcasing his active involvement in both academia and the biotechnology industry.
Mads Krogsgaard Thomsen's Education and Academic Credentials
Mads Krogsgaard Thomsen graduated as a Veterinarian (Cand.med.vet.) from the Faculty of Health Sciences at the University of Copenhagen in 1986. He earned his PhD from the same institution in 1989, further solidifying his expertise in veterinary medicine and pharmacology. His academic journey culminated in a Doctorate in Veterinary Medicine (dr.med.vet.) from the University of Copenhagen.
Mads Krogsgaard Thomsen's Career at Novo Nordisk
Mads Krogsgaard Thomsen began his career at Novo Nordisk in 1991. During his tenure, he held various significant roles, including Chief of Research in Growth Hormone, Research Director for Diabetes Research & Development, and Corporate Vice President of Research and Development. His contributions were crucial to the company, especially in the development of pharmaceutical products.
Mads Krogsgaard Thomsen's Contributions to Pharmaceutical Development
Throughout his career, Mads Krogsgaard Thomsen has played a key role in developing over 20 pharmaceutical products. His extensive experience in research and development has significantly impacted the healthcare and biotechnology sectors. His work spans various therapeutic areas, reflecting his broad expertise and influence in pharmaceutical innovation.
Mads Krogsgaard Thomsen's Leadership and Board Memberships
Mads Krogsgaard Thomsen has held leadership positions, including being the former chairman of the University of Copenhagen and president of the Academy of Technical Sciences. His leadership extends to corporate governance as well, with his current role on the board of BB Biotech AG. These roles underline his experience in both academic and corporate settings.